» Articles » PMID: 38243591

Limitations of Apical Sparing Pattern in Cardiac Amyloidosis: a Multicentre Echocardiographic Study

Abstract

Aims: Although impaired left ventricular (LV) global longitudinal strain (GLS) with apical sparing is a feature of cardiac amyloidosis (CA), its diagnostic accuracy has varied across studies. We aimed to determine the ability of apical sparing ratio (ASR) and most common echocardiographic parameters to differentiate patients with confirmed CA from those with clinical and/or echocardiographic suspicion of CA but with this diagnosis ruled out.

Methods And Results: We identified 544 patients with confirmed CA and 200 controls (CTRLs) as defined above (CTRL patients). Measurements from transthoracic echocardiograms were performed using artificial intelligence software (Us2.AI, Singapore) and audited by an experienced echocardiographer. Receiver operating characteristic curve analysis was used to evaluate the diagnostic performance and optimal cut-offs for the differentiation of CA patients from CTRL patients. Additionally, a group of 174 healthy subjects (healthy CTRL) was included to provide insight on how patients and healthy CTRLs differed echocardiographically. LV GLS was more impaired (-13.9 ± 4.6% vs. -15.9 ± 2.7%, P < 0.0005), and ASR was higher (2.4 ± 1.2 vs. 1.7 ± 0.9, P < 0.0005) in the CA group vs. CTRL patients. Relative wall thickness and ASR were the most accurate parameters for differentiating CA from CTRL patients [area under the curve (AUC): 0.77 and 0.74, respectively]. However, even with the optimal cut-off of 1.67, ASR was only 72% sensitive and 66% specific for CA, indicating the presence of apical sparing in 32% of CTRL patients and even in 6% healthy subjects.

Conclusion: Apical sparing did not prove to be a CA-specific biomarker for accurate identification of CA, when compared with clinically similar CTRLs with no CA.

Citing Articles

International Validation of Echocardiographic AI Amyloid Detection Algorithm.

Duffy G, Oikonomou E, Hourmozdi J, Usuku H, Patel J, Stern L medRxiv. 2025; .

PMID: 39763545 PMC: 11702730. DOI: 10.1101/2024.12.14.24319049.


Prevalence of Transthyretin Amyloid Cardiomyopathy Among Acute Heart Failure Patients with Hypertrophy Across the Left Ventricular Ejection Fraction Spectrum.

Velliou M, Markos L, Qiuris S, Bezati S, Ventoulis I, Matsiras D J Clin Med. 2024; 13(23).

PMID: 39685562 PMC: 11642681. DOI: 10.3390/jcm13237103.


Echocardiographic red flags in transthyretin amyloid cardiomyopathy: all that glitters is not gold.

De Michieli L, Sinigiani G, Nistri S, Cipriani A Eur Heart J Imaging Methods Pract. 2024; 2(3):qyae114.

PMID: 39679325 PMC: 11645158. DOI: 10.1093/ehjimp/qyae114.


Echocardiographic red flags of ATTR cardiomyopathy a single centre validation.

Henein M, Pilebro B, Lindqvist P Eur Heart J Imaging Methods Pract. 2024; 2(3):qyae105.

PMID: 39679323 PMC: 11645131. DOI: 10.1093/ehjimp/qyae105.


Definitional Challenges in Understanding Hypertrophic Cardiomyopathy.

Federspiel J, Pfeifer J, Ramsthaler F, Reil J, Schmidt P, Sequeira V Diagnostics (Basel). 2024; 14(22).

PMID: 39594199 PMC: 11592529. DOI: 10.3390/diagnostics14222534.